join ocra
A non-profit volunteer organization comprised of Regulatory Affairs professionals, OCRA has over 700 members representing more than 225 companies in Orange County and surrounding areas.

Saturday, January 21, 2017

Yearly Event List

Events Calendar

January 2017
  • Monday 09 January 2017 - Sunday 12 March 2017
    SDSU "Hot Topic" Course in Regulatory Submissions: Electronic Submissionsby This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  Other Meetings

  • Tuesday 17 January 2017 09:30am - 04:00pm
    Day at the District Meeting at the FDA District Office in Irvineby This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

February 2017
  • Wednesday 08 February 2017
    Best Practices for Managing Social Media Communications for Drugs and Devices: Balancing the Demands of the FDA, FTC and SECby This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

March 2017
  • Wednesday 08 March 2017
    Best Practices for Pre-Market Submissions (including de Novo)by This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

April 2017
  • Wednesday 12 April 2017
    Reimbursementby This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

June 2017
  • Wednesday 07 June 2017 - Thursday 08 June 2017
    20th Annual FDA-OCRA Educational Conference "Managing Change: Riding the Global Regulatory Wave" at Westin South Coast Plaza in Costa Mesaby This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

August 2017
  • Saturday 19 August 2017 - Sunday 20 August 2017
    RAC Study Groupby This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

September 2017
  • Wednesday 13 September 2017
    Best Practices in Complaint Handling and Related Customer Communications and Adverse Event Reporting by This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

October 2017
  • Wednesday 11 October 2017
    CAPA: Successful Strategies for a Comprehensive Program by This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

November 2017
  • Wednesday 08 November 2017
    Compliance and 483s: Lessons Learned from Criminal Investigations by This email address is being protected from spambots. You need JavaScript enabled to view it.  ::  OCRA Meetings

Arivis

Jun 02, 2015 2101
arivis logo
Contact: Adair Turner, MS, RAC, Director of Regulatory and Clinical Operations…

Promedica International

Dec 14, 2016 360
alt
Contact: Terri Hopton, Manager, Business Development and Special Projects…

Greg Godfrey & Associates

Feb 03, 2011 3091
alt
Contact: Greg Godfrey, RAC, CQE, CQA - Owner & Principal Consultant Specialty: Devices

Enterey, Inc.

Apr 21, 2016 2601
alt
Contact: Tita Tavares, Business Development Manager Specialty: Biologics/Biotechnology,…

Kim Walker Consulting

Apr 28, 2014 1807
Contact: Kim Walker, MS, RAC (US & EU) Specialty: Devices, IVD, New Drugs/OTC,…

TUV SUD America

Apr 21, 2016 1981
alt
Contact: Dr. Royth von Hahn Specialty: Devices, IVD

Promenade Software, Inc.

Aug 26, 2016 1254
Contact: Frances Cohen, President Specialty: Devices, IVD

A Regulatory Consultants Group (RGC)

Mar 31, 2016 2853
alt
Contact: Trudy R. Papson Specialty: Auditing, Gap Analysis, Mock FDA Inspections for…

Strategic Regulatory Solutions, Inc.

Apr 13, 2012 16963
Contact: Gustavo Kobrin, PresidentSpecialty: Devices

Consultant Directory

Jan 23, 2016 4477
This directory supplies information about consultants providing regulatory, clinical, and…

Quintiles Consulting

Jun 01, 2015 5601
Contact: Phil Johnson, Senior Director, Quality & Compliance Services Specialty: New and…

Noblitt & Rueland

May 09, 2009 4888
Contact: Brent Noblitt, Senior PartnerSpecialty: Devices, IVDs, Biologics/Biotechnology
Text Size